Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252211974 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Suyeol Im und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Plasminogen Activator Inhibitor 1, Diabetes Mellitus, Type 2, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Research Foundation of Korea (NRF), Basic Science Research Program.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Exposure to environment-polluting chemicals (EPCs), which are ligands of the aryl hydrocarbon receptor (AhR), is associated with the development of type 2 diabetes (T2D). This study explores the mechanisms by which AhR ligands contribute to β-cell failure in T2D. Incubation of RINm5F rat pancreatic β-cells with low-dose 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent AhR ligand, inhibited glucose-stimulated insulin secretion (GSIS). A single injection of TCDD in wild type mice reduced the size of Langerhans islets, but not in AhR liver knock-out mice (AhR-LKO). RNA-seq database analysis identified Serpine1, encoding for plasminogen activator inhibitor type-1 (PAI-1) as a TCDD-mediated secretory protein that is synthesized in an AhR-dependent manner in the liver. Elevated PAI-1 levels were shown to induce Caspase-3/7-dependent apoptosis in RINm5F cells, suggesting a novel pathway through which EPCs exacerbate T2D. These findings support the hypothesis that chronic exposure to AhR ligands may directly inhibit GSIS in pancreatic β-cells and indirectly induce β-cell apoptosis through increased PAI-1. This study provides new insights into the EPC-PAI-1 axis as a missing link between pancreatic β-cell failure and the progression of T2D and offers a potential target for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Physiology, School of Medicine, Biomedical Science Institute, Kyung Hee University, Seoul 02447, Republic of Korea.
- Department of Neuroscience, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
ORCID-Profile: Suyeol Im, Sora Kang, Hye Ji Yoon, Youngmi Kim Pak
Förderung
- the National Research Foundation of Korea (NRF)
- Basic Science Research Program
Zitieren
APA
Im, S., Kang, S., Son, W. J., Son, M., Oh, S. J., Yoon, H. J., & Pak, Y. K. (2024). Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252211974
Vancouver
Im S, Kang S, Son WJ, Son M, Oh SJ, Yoon HJ, et al. Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252211974
BibTeX
@article{Im2024,
author = {Im, Suyeol and Kang, Sora and Son, Woo Jung and Son, Minuk and Oh, Seung Jun and Yoon, Hye Ji and Pak, Youngmi Kim},
title = {Dioxin-Induced PAI-1 Expression: A Novel Pathway to Pancreatic β-Cell Failure in Type 2 Diabetes},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252211974}
}
EUVIMED